A preliminary review by the U.S. Food and Drug Administration questioned whether Sanofi SA’s experimental diabetes drug lixisenatide contributed any…
Read More
A preliminary review by the U.S. Food and Drug Administration questioned whether Sanofi SA’s experimental diabetes drug lixisenatide contributed any…
Read More